GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GI Innovation Inc (XKRX:358570) » Definitions » Beneish M-Score

GI Innovation (XKRX:358570) Beneish M-Score : -3.36 (As of Jun. 18, 2024)


View and export this data going back to 2023. Start your Free Trial

What is GI Innovation Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.36 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for GI Innovation's Beneish M-Score or its related term are showing as below:

XKRX:358570' s Beneish M-Score Range Over the Past 10 Years
Min: -26.12   Med: -3.36   Max: 9.25
Current: -3.36

During the past 5 years, the highest Beneish M-Score of GI Innovation was 9.25. The lowest was -26.12. And the median was -3.36.


GI Innovation Beneish M-Score Historical Data

The historical data trend for GI Innovation's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GI Innovation Beneish M-Score Chart

GI Innovation Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
- - - - -6.86

GI Innovation Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.77 -7.86 -26.12 -3.34 -3.36

Competitive Comparison of GI Innovation's Beneish M-Score

For the Biotechnology subindustry, GI Innovation's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GI Innovation's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GI Innovation's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where GI Innovation's Beneish M-Score falls into.



GI Innovation Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of GI Innovation for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.401+0.528 * 1+0.404 * 1.8736+0.892 * 1.5266+0.115 * 0.8145
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.4651+4.679 * -0.214102-0.327 * 1.668
=-3.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₩1,473 Mil.
Revenue was 24.281 + 4730.95 + 0 + 587.899 = ₩5,343 Mil.
Gross Profit was 24.281 + 4730.95 + 0 + 587.899 = ₩5,343 Mil.
Total Current Assets was ₩36,305 Mil.
Total Assets was ₩66,801 Mil.
Property, Plant and Equipment(Net PPE) was ₩7,964 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,250 Mil.
Selling, General, & Admin. Expense(SGA) was ₩37,454 Mil.
Total Current Liabilities was ₩4,724 Mil.
Long-Term Debt & Capital Lease Obligation was ₩2,812 Mil.
Net Income was -14400.179 + -11585.791 + -10571.15 + -20627.93 = ₩-57,185 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -11575.792 + -6096.185 + -10427.773 + -14782.976 = ₩-42,883 Mil.
Total Receivables was ₩2,406 Mil.
Revenue was 0 + 0 + 3500 + 0 = ₩3,500 Mil.
Gross Profit was 0 + 0 + 3500 + 0 = ₩3,500 Mil.
Total Current Assets was ₩86,000 Mil.
Total Assets was ₩117,768 Mil.
Property, Plant and Equipment(Net PPE) was ₩10,567 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩3,265 Mil.
Selling, General, & Admin. Expense(SGA) was ₩52,748 Mil.
Total Current Liabilities was ₩4,598 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,367 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1472.711 / 5343.13) / (2405.872 / 3500)
=0.275627 / 0.687392
=0.401

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3500 / 3500) / (5343.13 / 5343.13)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (36305.041 + 7963.65) / 66801.387) / (1 - (85999.693 + 10566.64) / 117768.12)
=0.337309 / 0.18003
=1.8736

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5343.13 / 3500
=1.5266

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(3264.747 / (3264.747 + 10566.64)) / (3249.76 / (3249.76 + 7963.65))
=0.236039 / 0.28981
=0.8145

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(37454.358 / 5343.13) / (52747.717 / 3500)
=7.009816 / 15.070776
=0.4651

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2811.723 + 4724.364) / 66801.387) / ((3366.713 + 4598.416) / 117768.12)
=0.112813 / 0.067634
=1.668

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-57185.05 - 0 - -42882.726) / 66801.387
=-0.214102

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

GI Innovation has a M-score of -3.36 suggests that the company is unlikely to be a manipulator.


GI Innovation Beneish M-Score Related Terms

Thank you for viewing the detailed overview of GI Innovation's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


GI Innovation (XKRX:358570) Business Description

Traded in Other Exchanges
N/A
Address
Songpa-daero 167, Room 1116 of A-dong, Songpa-gu, Seoul, KOR, 05855
GI Innovation Inc is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.

GI Innovation (XKRX:358570) Headlines

No Headlines